Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients

To evaluate the efficacy of treatments in spinocerebellar ataxias (SCAs), appropriate clinical scales are required. This study evaluated metric properties of the International Cooperative Ataxia Rating Scale (ICARS) in 156 SCA patients and 8 controls. ICARS was found to be a reliable scale satisfying accepted criteria for interrater reliability, test–retest reliability, and internal consistency. Although validity testing was limited, we found evidence of validity of ICARS when ataxia disease stages and Barthel index were used as external criteria. On the other hand, our study revealed two major problems associated with the use of ICARS. First, the redundant and overlapping nature of several items gave rise to a considerable number of contradictory ratings. Second, a factorial analysis showed that the rating results were determined by four different factors that did not coincide with the ICARS subscales, thus questioning the justification of ICARS subscore analysis in clinical trials. © 2006 Movement Disorder Society

[1]  A. Durr,et al.  Clinical and genetic aspects of spinocerebellar degeneration , 2000, Current opinion in neurology.

[2]  J. Wuu,et al.  Tremor and ataxia in fragile X premutation carriers: Blinded videotape study , 2003, Annals of neurology.

[3]  Elsdon Storey,et al.  Inter‐rater reliability of the International Cooperative Ataxia Rating Scale (ICARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[4]  H. Diener,et al.  Chapter 17 – Coordination and Ataxia , 2007 .

[5]  L. Provinciali,et al.  Botulinum toxin type A for drooling in Parkinson's disease: A double‐blind, randomized, placebo‐controlled study , 2006, Movement disorders : official journal of the Movement Disorder Society.

[6]  K. Nakashima,et al.  Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration , 2002, Journal of the Neurological Sciences.

[7]  Jan B. M. Kuks,et al.  Textbook of Clinical Neurology , 2003 .

[8]  M. Hallett,et al.  International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome , 1997, Journal of the Neurological Sciences.

[9]  K. Jellinger,et al.  A Textbook of Clinical Neurology , 1928, The Indian Medical Gazette.

[10]  Thorsten Schmidt,et al.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.

[11]  W. Poewe,et al.  Application of the International Cooperative Ataxia Scale rating in multiple system atrophy , 2002, Movement disorders : official journal of the Movement Disorder Society.

[12]  E. Monrós,et al.  Friedreich's ataxia: idebenone treatment in early stage patients. , 2002, Neuropediatrics.

[13]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.

[14]  T Klockgether,et al.  The natural history of degenerative ataxia: a retrospective study in 466 patients. , 1998, Brain : a journal of neurology.

[15]  M. Maschke,et al.  Eyeblink conditioning in patients with hereditary ataxia: a one-year follow-up study , 2005, Experimental Brain Research.

[16]  M. Manto,et al.  Effects of the oral form of ondansetron on cerebellar dysfunction , 2003, Journal of Neurology.